| (Values in U.S. Thousands) | Dec, 2015 | Dec, 2014 | Dec, 2013 | Dec, 2012 | Dec, 2011 |
| Sales | 0 | 0 | 0 | 0 | 220 |
| Sales Growth | unch | unch | unch | -100.00% | unch |
| Net Income | -25,210 | -27,280 | -15,130 | -5,140 | -4,440 |
| Net Income Growth | +7.59% | -80.30% | -194.36% | -15.77% | unch |
Amarantus Bioscience Holdings Inc (AMBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Amarantus BioScience, Inc. is a biotechnology company. It focuses on discovering and developing treatments and diagnostics for diseases associated with protein misfolding and apoptosis centered around its patented therapeutic protein Mesencephalic Astrocyte-derived Neurotrophic Factor. Amarantus BioScience, Inc. is based in Sunnyvale, California.
Fiscal Year End Date: 12/31